Posaconazole liquid vs tablet formulation in lung transplant recipients.

about

Posaconazole liquid vs tablet formulation in lung transplant recipients.

Item

http://www.wikidata.org/entity/Q48354018

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Posaconazole liquid vs tablet formulation in lung transplant recipients.

@en

Posaconazole liquid vs tablet formulation in lung transplant recipients.

@nl

type

Item

label

Posaconazole liquid vs tablet formulation in lung transplant recipients.

@en

Posaconazole liquid vs tablet formulation in lung transplant recipients.

@nl

prefLabel

Posaconazole liquid vs tablet formulation in lung transplant recipients.

@en

Posaconazole liquid vs tablet formulation in lung transplant recipients.

@nl

P1476

Posaconazole liquid vs tablet formulation in lung transplant recipients.

@en

P2093

A Weber

http://www.w3.org/2001/XMLSchema#string

C Neurohr

http://www.w3.org/2001/XMLSchema#string

F Ceelen

http://www.w3.org/2001/XMLSchema#string

F Ihle

http://www.w3.org/2001/XMLSchema#string

G Zimmermann

http://www.w3.org/2001/XMLSchema#string

H Winter

http://www.w3.org/2001/XMLSchema#string

J Behr

http://www.w3.org/2001/XMLSchema#string

M Vogeser

http://www.w3.org/2001/XMLSchema#string

M Zoller

http://www.w3.org/2001/XMLSchema#string

N Kneidinger

http://www.w3.org/2001/XMLSchema#string

P2860

Posaconazole tablet pharmacokinetics: lack of effect of concomitant medications altering gastric pH and gastric motility in healthy subjects.

Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia.

Switching from posaconazole suspension to tablets increases serum drug levels in leukemia patients without clinically relevant hepatotoxicity.

Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients.

Posaconazole serum concentrations among cardiothoracic transplant recipients: factors impacting trough levels and correlation with clinical response to therapy

Effect of a high-fat meal on the pharmacokinetics of 300-milligram posaconazole in a solid oral tablet formulation.

Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults.

Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological Malignancies.

Retrospective Comparison of Posaconazole Levels in Patients Taking the Delayed-Release Tablet versus the Oral Suspension.

Suspected posaconazole toxicity in a pediatric oncology patient.

P304

186-194

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/MYC.12724

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

D Stelzer

P577

2017-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29110351

http://www.w3.org/2001/XMLSchema#string

P921

lung transplant